Jiajia Zhang

Jiajia Zhang

Auto-generated profile, based on publicly available information

Jiajia Zhang

Department of General Surgery, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YWYue Wang
Yue Wang
XYXin Yu
Xin Yu
BZBo Zhou
Bo Zhou
JZJiajia Zhang
Jiajia Zhang
JCJiacong Chang
Jiacong Chang
Human gastric cancer is one of the most common malignant tumors with a poor prognosis. Cisplatin (CDDP) is a well‐known first‐line chemotherapeutic drug. Acquired resistance retards the clinical application of CDDP in gastric cancer. In this study, circular RNA circ_0026359 was demonstrated to be overexpressed in gastric cancer tissues/cells compared with normal gastric tissues/cells and was overexpressed in CDDP‐resistant gastric cancer tissues/cells compared with CDDP‐sensitive gastric cancer tissues/cells. High levels of circ_0026359 were associated with low overall survival (OS) and relapse‐free survival (RFS) rates in gastric cancer patients. circ_0026359 was examined to promote CDDP resistance in gastric cancer cells. circ_0026359 directly interacted and negatively regulated miR‐1200. POLD4 was a direct target of miR‐1200. miR‐1200/POLD4 pathway mediated the promoting role of circ_0026359 in CDDP resistance of gastric cancer. circ_0026359 could be used as a potential target for CDDP‐resistant gastric cancer therapy.